Anthony B. Eason

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

12h-index471citations46works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral-associated cancers and disorders(15), SARS-CoV-2 and COVID-19 Research(9), Phytochemical compounds biological activities(9), Lymphoma Diagnosis and Treatment(7), Cytomegalovirus and herpesvirus research(6)

Publications46 total

Spatial Profiling Shows That Lymphatic Endothelial Cells Form the Core of Kaposi Sarcoma (KS)
Modern Pathology·2025Open Access
Scaling Biosafety Up During and Down After the COVID-19 Pandemic
UNC Libraries·2025Open Access
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants
UNC Libraries·2025Open Access
CD81 fusion alters SARS-CoV-2 Spike trafficking.
UNC Libraries·2024Open Access
Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi
UNC Libraries·2024· 2 citedOpen Access
CD81 fusion alters SARS-CoV-2 Spike trafficking
mBio·2024· 4 citedOpen Access
The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice
Cell Host & Microbe·2024· 16 citedOpen Access
Supplementary Table 1 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure Legend from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 3 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Table 1 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 2 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure Legend from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 1 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 3 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 1 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Data from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Data from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 2 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants
mBio·2023· 18 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Dirk P. Dittmer(44), Blossom Damania(25), Sang‐Hoon Sin(24), Veenadhari Chavakula(15), Debasmita Roy(14), Amy Lucas(14), Isaac B. Hilton(14), Kristen M. Tamburro(14), Ryan P. McNamara(11), Justin T. Landis(11), Raman Venkataramanan(11), Aubrey Bailey(9), Ling Wang(9), Carolina Caro‐Vegas(8), Angelica Juarez(8), Razia Moorad(7), Yijun Zhou(6), Linda Pluta(6), Femi Cleola S. Villamor(6), Jason P. Wong(6)